Suppr超能文献

幽门螺杆菌的脂多糖通过一氧化氮的产生来保护胃黏膜。

Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide.

作者信息

Brzozowski T, Konturek P C, Sliwowski Z, Drozdowicz D, Pajdo R, Stachura J, Hahn E G, Konturek S J

机构信息

Institute of Physiology, Jagiellonian University Medical School, Cracow, Poland.

出版信息

J Physiol Pharmacol. 1997 Dec;48(4):699-717.

PMID:9444618
Abstract

Lipopolysaccharide (LPS) has been proposed to act as the major virulence factor in Helicobacter pylori (Hp)-infected stomach but its action on mucosal integrity has been little studied. We determined the effects of LPS of Hp, expressing cytotoxic antigens CagA and VacA on acute gastric lesions induced by 100% ethanol, mucosal blood flow (GBF) and expression of constitutive nitric oxide (NO) synthase (cNOS) mRNA and inducible NO synthase (iNOS) mRNA in gastric mucosa using RT-PCR. Two major series (A and B) of rats were employed; A--with suppressed NOS activity by nonspecific NOS inhibitor, such as NG-nitro-L-arginine methyl ester, (L-NAME) (5 mg/kg i.v.), or by specific iNOS inhibitor, NG-(1-Immunoethyl) lysine (L-NIL) (30 mg/kg i.g.), or with inhibited induction of NOS activity by dexamethasone (2 mg/kg i.p.) and series B--vehicle (saline)-treated controls. LPS (0.01-1.0 mg/kg) given i.p. attenuated dose-dependently ethanol-induced mucosal lesions and this protective effect was accompanied by a rise in the GBF and excessive mucosal production and luminal release of NO. LPS (1 mg/kg i.p.) administered at lower dose (1 mg/kg i.p.) to rats without ethanol instillation significantly elevated GBF and luminal release of NO, while higher doses of LPS (20 and 40 mg/kg i.p.) or SNAP (6 mg/kg), which produced systemic hypotension, were not protective. Suppression of NOS activity by pretreatment with standard dose of L-NAME or L-NIL and inhibition of NOS induction by treatment with dexamethasone reversed the protective and hyperemic effects of LPS and this reversal was significantly antagonized by the addition of the substrate for cNOS, L-arginine, but not D-arginine. Administration of L-NAME, L-NIL or dexamethasone, completely abolished the enhanced mucosal NO production and the hyperemia induced by LPS in rats without or with topical application of ethanol. Expression of cNOS was detected by RT-PCR in the intact mucosa but intense signals for expression of both cNOS and iNOS were detected by RT-PCR in the gastric mucosa of LPS-treated rats. We conclude that parenteral LPS protects gastric mucosa from acute ethanol-induced damage via an increase in mucosal microcirculation mediated by NO due to the overexpression of iNOS and activation of arginine-NO-system.

摘要

脂多糖(LPS)被认为是幽门螺杆菌(Hp)感染胃中的主要毒力因子,但其对黏膜完整性的作用研究较少。我们使用逆转录聚合酶链反应(RT-PCR),测定了表达细胞毒性抗原CagA和VacA的Hp的LPS对100%乙醇诱导的急性胃损伤、黏膜血流量(GBF)以及胃黏膜中组成型一氧化氮(NO)合酶(cNOS)mRNA和诱导型NO合酶(iNOS)mRNA表达的影响。使用了两大组大鼠(A组和B组);A组——用非特异性NOS抑制剂如NG-硝基-L-精氨酸甲酯(L-NAME)(5mg/kg静脉注射)或特异性iNOS抑制剂NG-(1-免疫乙基)赖氨酸(L-NIL)(30mg/kg灌胃)抑制NOS活性,或用地塞米松(2mg/kg腹腔注射)抑制NOS活性诱导;B组——用溶剂(生理盐水)处理的对照组。腹腔注射LPS(0.01 - 1.0mg/kg)剂量依赖性地减轻乙醇诱导的黏膜损伤,这种保护作用伴随着GBF增加以及NO在黏膜过度产生和腔内释放。在未滴注乙醇的大鼠中,以较低剂量(1mg/kg腹腔注射)给予LPS(1mg/kg腹腔注射)可显著提高GBF和NO的腔内释放,而较高剂量的LPS(20和40mg/kg腹腔注射)或产生全身性低血压的硝普钠(SNAP,6mg/kg)则没有保护作用。用标准剂量的L-NAME或L-NIL预处理抑制NOS活性以及用地塞米松处理抑制NOS诱导可逆转LPS的保护和充血作用,并且添加cNOS的底物L-精氨酸可显著拮抗这种逆转,而D-精氨酸则不能。给予L-NAME、L-NIL或地塞米松可完全消除在未局部应用乙醇或局部应用乙醇的大鼠中LPS诱导的黏膜NO产生增加和充血。通过RT-PCR在完整黏膜中检测到cNOS的表达,但在LPS处理的大鼠胃黏膜中通过RT-PCR检测到cNOS和iNOS表达的强烈信号。我们得出结论,胃肠外给予LPS可通过iNOS过表达和精氨酸-NO系统激活介导的NO增加黏膜微循环,从而保护胃黏膜免受急性乙醇诱导的损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验